Also categorized in Global Health:
FDA approves an Ebola vaccine, long in development, for the first time - Stat
x hide permanently

This Asthma Drug Can Boost Recovery in COVID-19

News Break

Photo: CC0 Public Domain

In a new study from the University of Oxford, researchers found that early treatment with an asthma drug budesonide shortens recovery time in COVID-19 patients aged over 50 who are treated at home.

They found clear evidence of an effective COVID-19 treatment for use in primary care that can significantly shorten recovery time.

Inhaled budesonide is a safe, relatively inexpensive, and readily available corticosteroid commonly used around the world in inhalers to treat asthma and chronic obstructive pulmonary disease.

In the study, a total of 961 patients were assigned to receive inhaled budesonide at ...